Pentaazacentopthylene Uses, Dosage, Side Effects and more
Pentaazacentopthylene has been used in trials studying the treatment of Leukemia, Ovarian Cancer, HER2/Neu Negative, Breast Adenocarcinoma, and Stage IV Breast Cancer, among others.
| Attribute | Details |
|---|---|
| Trade Name | Pentaazacentopthylene |
| Generic | Triciribine |
| Triciribine Other Names | Pentaazacentopthylene, TCN, Triciribina, Triciribine, Triciribinum |
| Type | |
| Formula | C13H16N6O4 |
| Weight | Average: 320.309 Monoisotopic: 320.123303019 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
